Bioengineered Nanomaterials for Wound Healing and Infection Control
- 1st Edition - August 1, 2023
- Imprint: Woodhead Publishing
- Editors: Hamed Barabadi, Muthupandian Saravanan, Ebrahim Mostafavi, Hossein Vahidi
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 3 7 6 - 4
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 8 3 5 - 6
Bioengineered Nanomaterials for Wound Healing and Infection Control is a key reference for those working in the fields of materials science, pharmacy, nanotechnology, biomed… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteBioengineered Nanomaterials for Wound Healing and Infection Control is a key reference for those working in the fields of materials science, pharmacy, nanotechnology, biomedical engineering and microbiology. Bioengineered nanomaterials have unique physicochemical properties which promote accelerated wound healing and treatment of infections. The biosynthesis of these nanomaterials also offers a clean, safe and renewable alternative to traditional nanomaterials, helping reduce environmental impact alongside antibacterial resistance.
- Provides an overview of the role of biofilms and multidrug resistance in wound infections
- Covers a range of bioengineered nanomaterial types and nanotechnology-based approaches, including phyconanotechnology, phytonanotechnology and microbial nanotechnology
- Helps readers discover novel materials for use in wound healing and infection control while reducing the probability of antibiotic resistance
Researchers and academics in the fields of materials science, biomedical engineering, pharmaceutical science and nanotechnology. Researchers in the fields of microbiology and regenerative medicine with an interest in materials for wound healing and infection control
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- About the editors
- Preface
- Chapter 1. An overview of antimicrobial resistance and its mechanisms
- Abstract
- 1.1 Introduction
- 1.2 Origins and types of resistance to antimicrobial agents
- 1.3 The complex issues of antimicrobial resistance reversibility and fitness
- 1.4 Mechanisms of antimicrobial action
- 1.5 Mechanisms of antimicrobial resistance
- 1.6 Current challenges
- 1.7 Conclusion
- Acknowledgment
- References
- Chapter 2. An overview of wound healing: wound types and current therapeutics
- Abstract
- 2.1 Introduction
- 2.2 Physiology of wound healing
- 2.3 Wound classification
- 2.4 Factors impairing wound healing
- 2.5 Barriers to drug delivery to the wound
- 2.6 Current therapeutic approaches
- 2.7 Conclusion
- References
- Chapter 3. The role of biofilms and multidrug resistance in wound infections
- Abstract
- Abbreviations
- 3.1 Introduction
- 3.2 Multidrug resistance in wound infections
- 3.3 Prevention and control of wound infections
- 3.4 Conclusions and future directions
- Acknowledgments
- Conflict of interest
- References
- Chapter 4. Wound healing and nanotechnology: opportunities and challenges
- Abstract
- 4.1 Introduction
- 4.2 Wound and its classification
- 4.3 Wound healing process
- 4.4 Current procedures in wound management
- 4.5 Conclusion and future perspectives
- References
- Chapter 5. Nanotechnology-based therapeutics to combat biofilms and antibacterial resistance in chronic wound infections
- Abstract
- 5.1 Introduction
- 5.2 Development of chronic wound
- 5.3 Limitations in current wound therapy
- 5.4 Advancements in wound dressings and coatings
- 5.5 Nanotherapeutics for wound care
- 5.6 Nanoparticles with antimicrobial properties
- 5.7 Conclusion
- References
- Chapter 6. Smart nanosystems for wound healing and infection control
- Abstract
- 6.1 Introduction
- 6.2 Classification of smart nanomaterials
- 6.3 Synthesis of smart nanomaterials
- 6.4 Recent methods for synthesis
- 6.5 Magnetic responsive nanomaterials
- 6.6 Light-responsive nanomaterials
- 6.7 Temperature-responsive nanomaterials
- 6.8 Electrical and electrochemical stimuli-responsive nanomaterials
- 6.9 pH-responsive nanomaterials
- 6.10 Redox-responsive nanomaterials
- 6.11 Enzyme/toxin-responsive nanomaterials
- 6.12 Biological functions of miRNA
- 6.13 Future directions
- 6.14 Conclusion
- Acknowledgment
- Conflict of interest
- Authors’ contribution
- References
- Chapter 7. Bioengineering of nanomaterials using biological resources: biofabrication mechanisms, characterizations, and biomedical applications
- Abstract
- 7.1 Introduction
- 7.2 Fabrication of metal-based nanomaterials
- 7.3 Large-scale production of biosynthesized nanomaterials
- 7.4 Characterization of biogenic metal–based nanomaterials
- 7.5 Advantages and limitations of biological methods in nanomaterials’ synthesis
- 7.6 Biomedical application of bioengineered metal–based nanomaterials: recent advances
- 7.7 Future challenges and conclusion
- References
- Chapter 8. Bacteria-derived nanobiomaterials: exploration of their wound healing, antimicrobial, and biofilm inhibitory activities
- Abstract
- 8.1 Introduction
- 8.2 Synthesis of nanoparticles
- 8.3 Physicochemical properties of bacteria-synthesized nanoparticles
- 8.4 Potential use of biogenic nanoparticles
- 8.5 Prospects for the use of bacteria-synthesized nanoparticles: current status and prediction
- 8.6 Final remarks
- References
- Chapter 9. Mycosynthesis of nanobiomaterials and their wound healing, antimicrobial, and biofilm inhibitory activities
- Abstract
- 9.1 Introduction
- 9.2 Synthesis of nanomaterials
- 9.3 Factors affecting the mycosynthesis of nanobiomaterials
- 9.4 Characterization of nanobiomaterials
- 9.5 Activities of mycosynthesized nanobiomaterials and applications
- 9.6 Limitations and challenges
- 9.7 Conclusive remarks and future perspectives
- References
- Chapter 10. Bioengineering of nanomaterials using micro- and macroalgae and their wound healing, antimicrobial, and biofilm inhibitory activities
- Abstract
- 10.1 Introduction
- 10.2 Microalgae- and macroalgae-mediated biosynthesis of nanomaterials and their characterization
- 10.3 Potential of algal nanotechnology in wound healing, antimicrobial, and biofilm inhibition activities
- 10.4 Challenges in the clinical development of phycosynthesized nanomaterials
- 10.5 Conclusion and future perspectives
- References
- Chapter 11. Phytonanotechnology: a greener approach for bioengineering of nanomaterials and their wound healing, antimicrobial, and biofilm inhibitory activities
- Abstract
- 11.1 Phytonanotechnology: emerging paradigms
- 11.2 The interface of nanotechnology, plant, and microbes
- 11.3 Production of green nanomaterials from plant extracts
- 11.4 Optimization and characterization of biological nanomaterials
- 11.5 The antibacterial and wound healing potential of phytonanotechnology
- 11.6 Challenges in clinical development of biogenic nanobiomaterials
- 11.7 Conclusion and prospective development
- References
- Chapter 12. Bioengineered silver nanoparticles for antimicrobial therapeutics
- Abstract
- 12.1 Introduction
- 12.2 Microbial resistance; a global concern
- 12.3 Current nanotherapeutics to combat microbial resistance
- 12.4 Green nanotechnology: an overview
- 12.5 Bioengineering of silver nanomaterials
- 12.6 Antimicrobial potential of bioengineered silver nanomaterials
- 12.7 Conclusion and future outlook
- References
- Chapter 13. Bioengineered gold nanoparticles for antimicrobial therapeutics
- Abstract
- 13.1 Nanoscience and nanotechnology: an introduction
- 13.2 Nanomaterials: types, properties, and applications
- 13.3 Resistance to antibiotics: a global threat
- 13.4 Nanostrategies to prevent microbial infections
- 13.5 Gold nanoparticles: properties and biomedical applications
- 13.6 Biological synthesis of gold nanoparticles
- 13.7 Antimicrobial performance of biosynthesized gold nanoparticles
- 13.8 Conclusions and future outlook
- References
- Chapter 14. Green nanotechnology–based selenium and titanium dioxide nanomaterials for antimicrobial applications
- Abstract
- 14.1 Nanobiotechnology: an overview
- 14.2 Selenium nanomaterials: properties, characteristics, and applications
- 14.3 Titanium dioxide nanomaterials: properties, characteristics, and applications
- 14.4 Green nanotechnology–based approaches for the biosynthesis of selenium and titanium dioxide nanomaterials
- 14.5 Antimicrobial performance of biogenic selenium nanomaterials
- 14.6 Antimicrobial performance of biogenic titanium dioxide nanomaterials
- 14.7 Conclusions and future outlook
- References
- Chapter 15. Opportunities and challenges for bioengineered metallic nanoparticles as future nanomedicine
- Abstract
- 15.1 Introduction
- 15.2 A brief history of biologically synthesized metal nanoparticles
- 15.3 Market prospects and opportunities
- 15.4 Challenges and future perspectives
- 15.5 Conclusion
- Acknowledgment
- References
- Index
- Edition: 1
- Published: August 1, 2023
- No. of pages (Paperback): 590
- No. of pages (eBook): 390
- Imprint: Woodhead Publishing
- Language: English
- Paperback ISBN: 9780323953764
- eBook ISBN: 9780323958356
HB
Hamed Barabadi
Hamed Barabadi (PharmD, PhD) works as an assistant professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He received a PhD degree from Shahid Beheshti University of Medical Sci-ences, Tehran, Iran, in 2019. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. He owns to his credit a number of research papers, book chapters, and edited books with more than 3000 citations and h-index of 38. He has received many awards such as IET—Nanobiotech¬nology Premium Awards two times continuously in the years 2019 and 2020. Dr. Barabadi has been featured among the World’s Top 2% scientists list, according to a Stanford University study 2020 and 2022. He is the guest editor/editor for various reputed indexed journals such as Current Nanomedicine, Nanoscience and Nanotechnology-Asia, Frontiers in Pharmacology, MDPI International Journal of Molecular Sciences, MDPI Molecules, and a few other prestigious journals. His research interests lie in the area of pharmaceutical nanobiotechnology, ranging from green synthesis, characterization, and optimization of nanobiomaterials to their pharmaceutical potential evaluations, such as anticancer, antimicrobial, antioxidant, etc. Moreover, he has collaborated actively with researchers in several other disciplines of pharmaceutical sciences, particularly the nanoformulation of drugs for drug delivery systems and nanomedicine.
Affiliations and expertise
Assistant Professor, Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IranMS
Muthupandian Saravanan
Dr. Muthupandian Saravanan is currently a Professor in the Department of Pharmacology at Saveetha University, SIMATS, Chennai, India. He has a degree in Microbiology from Madurai Kamaraj University and a Doctorate with Specialization in Medical Microbiology and Nanomedicine from Sathyabama University, India. As a Post-Doctoral Researcher at the Hebrew University of Jerusalem, he studied nano-biomaterials and their biomedical applications. He later worked as Associate Professor, under the United Nation Development Program in Department of Medical Microbiology and Immunology at Mekelle University in Ethiopia. He has published papers in high impact journals such as the Lancet and Nature. He has participated in more than 75 national and international conferences and reviewed of more than 100 international peer-reviewed journals. He has served as guest editor/ co-editor for reputed PubMed and Scopus indexed journals. He has received many fellowships and awards, notably the IET- Nanobiotechnology premium Awards in 2019 and 2020.
Affiliations and expertise
Professor, AMR and Nanotherapeutics Lab, Department of Pharmacology Saveetha Institute of Medical and Technical Sciences (SIMATS)EM
Ebrahim Mostafavi
Dr. Ebrahim Mostafavi has so far received training at Stanford University School of Medicine (PostDoc), Northeastern University (PhD), Harvard Medical School (Researcher), and University of Tehran (MSc and BSc). His research interests revolve around the engineering and development of (nano)biomaterials, nanocarriers, and 3D in vitro models (hydrogels, 3D bioprinted constructs, nanofibrous scaffolds, organoids, vascular grafts, and microfluidic systems) to create biologically complex systems for a range of applications such as cancer diagnostics and therapeutics, tissue engineering and regenerative medicine, biosensing, and infectious diseases. Dr. Mostafavi serves as an associate editor-in-chief of several prestigious and high-impact journals within Elsevier, Springer, Cell Press, Dove Medical Press, T&F, Frontiers, and so on He is also an editorial board member of more than 30 impactful and prestigious biomedical and materials science journals. His scholarly work comprises more than 200 publications with an H-index of 36 (i10-index of 105), including papers published in The Lancet family (i.e., Oncology, Infectious Diseases, Public Health, and Global Health) journals. So far, he has edited several books such as “Pharmaceutical Nanobiotechnology for Targeted Therapy” and “Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance”. He has also contributed to leading more than 45 introductory book chapters in a very multidisciplinary field of bio/medical engineering, biotechnology, nanotechnology, materials science, and regenerative/ translational medicine.
Affiliations and expertise
Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USAHV
Hossein Vahidi
Hossein Vahidi (PharmD, PhD) is a Professor and head of the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran. He is currently head of the School of Pharmacy and Director-in-Charge of the Iranian Journal of Pharmaceutical Research (IJPR). His research interests lie in the area of bioprocessing and fermentation of microorganisms for the production of bioactive compounds, optimization of fermentation, and growth of industrial microorganisms.
Affiliations and expertise
Professor and Head, Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, IranRead Bioengineered Nanomaterials for Wound Healing and Infection Control on ScienceDirect